Rice and MD Anderson launch Cancer Bioengineering Collaborative
June 27, 2024
Rice and the University of Texas MD Anderson Cancer Center today announced the creation of the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment.
Rice’s new Synthesis X Center has winning formula for cancer innovation
March 21, 2024
Rice has created the new Synthesis X Center to bring together clinicians treating cancer and researchers looking for cures to help spur drug discovery make precision adjustments to drug properties and translate fundamental research discoveries into clinical applications.
Rice’s Wiess School launches Center for Nanoscale Imaging Sciences
March 4, 2024
The Wiess School of Natural Sciences at Rice University has launched the Center for Nanoscale Imaging Sciences to improve the capture, analysis and interpretation of images at the nanometer scale. The center will push the frontiers of nanoscale imaging, contributing to breakthroughs in fields such as nanotechnology, materials science, biology and biomedicine.
Fluorine catch-and-attach process could boost drug efficiency
November 13, 2023
Rice scientists have developed a new low-cost, safe and effective process to free up and reattach fluorine to chemical compounds. In pharmaceuticals, fluorine can expand lifetime, increase absorption and minimize side effects.
Two Rice bioengineers win NIH Director’s New Innovator awards
October 3, 2023
Rice bioengineers Jerzy Szablowski and Julea Vlassakis received the NIH Director’s New Innovator Award for their respective research projects. Szablowski’s work seeks to develop a noninvasive method of mapping gene expression, while Vlassakis is studying complex, single-cell level processes and interactions in pediatric bone cancer.